Literature DB >> 23481523

The UK National Health Service: delivering equitable treatment across the spectrum of coronary disease.

Nathaniel M Hawkins1, Shaun Scholes, Madhavi Bajekal, Hande Love, Martin O'Flaherty, Rosalind Raine, Simon Capewell.   

Abstract

BACKGROUND: Social gradients in cardiovascular mortality across the United Kingdom may reflect differences in incidence, disease severity, or treatment. It is unknown whether a universal healthcare system delivers equitable lifesaving medical therapy for coronary heart disease. We therefore examined secular trends in the use of key medical therapies stratified by socioeconomic circumstances across a broad spectrum of coronary disease presentations, including acute coronary syndromes, secondary prevention, and clinical angina. METHODS AND
RESULTS: This was a cross-sectional observational analysis of nationally representative primary and secondary care data from the United Kingdom. Data on treatments for all myocardial infarction patients in 2003 and 2007 were derived from the Myocardial Ischemia National Audit Project (n=51 755). Data on treatments for patients with chronic angina (n=33 211) or requiring secondary prevention (n=32 976) in 1999 and 2007 were extracted from the General Practice Research Database. Socioeconomic circumstances were defined using a weighted composite of 7 area-level deprivation domains. Treatment estimates were age-standardized. Use of all therapies increased in all patient groups, both men and women. Improvements were most marked in primary care, where use of β-blockers, statins, and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for secondary prevention and treatment of angina doubled, from ≈30% to >60%. Small age gradients persisted for some therapies. No consistent socioeconomic gradients or sex differences were observed for myocardial infarction and postrevascularization (hard diagnoses). However, some sex inequality was apparent in the treatment of younger women with angina.
CONCLUSIONS: Cardiovascular treatment is generally equitable and independent of socioeconomic circumstances. Future strategies should aim to further increase overall treatment levels and to eradicate remaining age and sex inequalities.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23481523     DOI: 10.1161/CIRCOUTCOMES.111.000058

Source DB:  PubMed          Journal:  Circ Cardiovasc Qual Outcomes        ISSN: 1941-7713


  16 in total

1.  Sex Differences in Outcomes Following Percutaneous Coronary Intervention According to Age.

Authors:  Kelly C Epps; Elizabeth M Holper; Faith Selzer; Helen A Vlachos; Sarah K Gualano; J Dawn Abbott; Alice K Jacobs; Oscar C Marroquin; Srihari S Naidu; Peter W Groeneveld; Robert L Wilensky
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2016-02

Review 2.  Young Women With Acute Myocardial Infarction: Current Perspectives.

Authors:  Rachel P Dreyer; Christopher Sciria; Erica S Spatz; Basmah Safdar; Gail D'Onofrio; Harlan M Krumholz
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2017-02-22

3.  Potential of trans fats policies to reduce socioeconomic inequalities in mortality from coronary heart disease in England: cost effectiveness modelling study.

Authors:  Kirk Allen; Jonathan Pearson-Stuttard; William Hooton; Peter Diggle; Simon Capewell; Martin O'Flaherty
Journal:  BMJ       Date:  2015-09-15

4.  Trends in myocardial infarction secondary prevention: The National Health and Nutrition Examination Surveys (NHANES), 1999-2012.

Authors:  Nilay S Shah; Mark D Huffman; Hongyan Ning; Donald M Lloyd-Jones
Journal:  J Am Heart Assoc       Date:  2015-04-22       Impact factor: 5.501

5.  The impact of social deprivation on mortality following acute myocardial infarction, stroke or subarachnoid haemorrhage: a record linkage study.

Authors:  Kymberley Thorne; John G Williams; Ashley Akbari; Stephen E Roberts
Journal:  BMC Cardiovasc Disord       Date:  2015-07-18       Impact factor: 2.298

6.  Socially disadvantaged city districts show a higher incidence of acute ST-elevation myocardial infarctions with elevated cardiovascular risk factors and worse prognosis.

Authors:  J Schmucker; S Seide; H Wienbergen; E Fiehn; J Stehmeier; K Günther; W Ahrens; R Hambrecht; H Pohlabeln; A Fach
Journal:  BMC Cardiovasc Disord       Date:  2017-09-22       Impact factor: 2.298

7.  Trends of relative and absolute socioeconomic equity in access to coronary revascularisations in 1995-2010 in Finland: a register study.

Authors:  Sonja Lumme; Kristiina Manderbacka; Ilmo Keskimäki
Journal:  Int J Equity Health       Date:  2017-02-20

Review 8.  Inequalities in care in patients with acute myocardial infarction.

Authors:  Shabnam Rashid; Alexander Simms; Phillip Batin; John Kurian; Chris P Gale
Journal:  World J Cardiol       Date:  2015-12-26

9.  Quantifying the Socio-Economic Benefits of Reducing Industrial Dietary Trans Fats: Modelling Study.

Authors:  Jonathan Pearson-Stuttard; Julia Critchley; Simon Capewell; Martin O'Flaherty
Journal:  PLoS One       Date:  2015-08-06       Impact factor: 3.240

10.  Evaluating quality and its determinants in lipid control for secondary prevention of heart disease and stroke in primary care: a study in an inner London Borough.

Authors:  Hiten Dodhia; Liu Kun; Hugh Logan Ellis; James Crompton; Anthony S Wierzbicki; Helen Williams; Anna Hodgkinson; John Balazs
Journal:  BMJ Open       Date:  2015-12-09       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.